These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 447434

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Methadone treatment: program evaluation and dose response relationships.
    Handal PJ, Lander JJ.
    Int J Addict; 1976; 11(3):363-75. PubMed ID: 965120
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Withdrawal from methadone maintenance. Rate of withdrawal and expectation.
    Senay EC, Dorus W, Goldberg F, Thornton W.
    Arch Gen Psychiatry; 1977 Mar; 34(3):361-7. PubMed ID: 843188
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Voluntary detoxification of patients on methadone maintenance.
    Berger H, Schwegler MJ.
    Int J Addict; 1973 Mar; 8(6):1043-7. PubMed ID: 4790685
    [No Abstract] [Full Text] [Related]

  • 31. Retention in a low-threshold methadone maintenance program.
    Torrens M, Castillo C, Pérez-Solá V.
    Drug Alcohol Depend; 1996 May; 41(1):55-9. PubMed ID: 8793310
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A 12-year follow-up of a methadone medical maintenance program.
    Schwartz RP, Brooner RK, Montoya ID, Currens M, Hayes M.
    Am J Addict; 1999 May; 8(4):293-9. PubMed ID: 10598212
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Double-blind detoxification of methadone maintenance patients.
    Mintz J, O'Brien CP, O'Hare K, Goldschmidt J.
    Int J Addict; 1975 May; 10(5):815-24. PubMed ID: 1176233
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Phase III clinical study of LAAM: report of current status and analysis of early terminations.
    Whysner JA, Levine GL.
    NIDA Res Monogr; 1978 May; (19):277-90. PubMed ID: 106293
    [No Abstract] [Full Text] [Related]

  • 40. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization.
    Judson BA, Goldstein A.
    Drug Alcohol Depend; 1979 Nov; 4(6):461-6. PubMed ID: 533680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.